Ilpo Huhtaniemi Selected Research

inhibin-alpha subunit

6/2008	Targeted therapy for adrenocortical tumors in transgenic mice through their LH receptor by Hecate-human chorionic gonadotropin beta conjugate.
5/2005	A novel targeted therapy of Leydig and granulosa cell tumors through the luteinizing hormone receptor using a hecate-chorionic gonadotropin beta conjugate in transgenic mice.
10/2004	Adrenocortical tumorigenesis in transgenic mice expressing the inhibin alpha-subunit promoter/simian virus 40 T-antigen transgene: relationship between ectopic expression of luteinizing hormone receptor and transcription factor GATA-4.
5/2003	High levels of luteinizing hormone analog stimulate gonadal and adrenal tumorigenesis in mice transgenic for the mouse inhibin-alpha-subunit promoter/Simian virus 40 T-antigen fusion gene.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ilpo Huhtaniemi Research Topics

Disease

25	Neoplasms (Cancer) 01/2022 - 10/2002
13	Infertility (Sterility) 07/2015 - 03/2002
10	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2020 - 01/2003
9	Carcinogenesis 01/2017 - 05/2003
6	Hyperplasia 01/2017 - 03/2006
4	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 09/2007
4	Prolactinoma (Prolactinomas) 01/2017 - 04/2005
3	Breast Neoplasms (Breast Cancer) 01/2020 - 05/2003
3	Cardiovascular Diseases (Cardiovascular Disease) 04/2016 - 04/2008
3	Inflammation (Inflammations) 04/2016 - 03/2006
3	Granulosa Cell Tumor 03/2014 - 05/2005
3	Precocious Puberty 01/2014 - 01/2003
3	Azoospermia 02/2011 - 11/2003
2	Adenoma (Adenomas) 01/2017 - 10/2002
2	Adenocarcinoma 01/2017 - 10/2013
2	Erectile Dysfunction 03/2014 - 04/2011
2	Ovarian Neoplasms (Ovarian Cancer) 03/2014 - 01/2012
2	Body Weight (Weight, Body) 01/2012 - 12/2003
2	Pituitary Neoplasms (Pituitary Adenoma) 09/2010 - 03/2004
2	Amenorrhea 03/2010 - 03/2002
2	Primary Ovarian Insufficiency 02/2010 - 03/2002
2	Carcinoma (Carcinomatosis) 06/2005 - 05/2003
1	Hyperthyroidism 01/2022
1	Congenital Hypothyroidism (Cretinism) 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Heart Failure 01/2020
1	46,XY Disorder of Sex Development (Male Pseudohermaphroditism) 08/2019
1	Adrenocortical Carcinoma 01/2019
1	Lewis Lung Carcinoma 10/2018
1	Oligospermia (Oligozoospermia) 09/2018
1	Cushing Syndrome 01/2017
1	Acute Coronary Syndrome 04/2016
1	Persistent Infection 04/2016
1	Endometriosis 01/2016
1	Ovarian Hyperstimulation Syndrome 01/2014
1	Choriocarcinoma 04/2013
1	Non-alcoholic Fatty Liver Disease 02/2013

Drug/Important Bio-Agent (IBA)

13	Luteinizing Hormone (Lutropin)FDA LinkGeneric 01/2019 - 05/2003
13	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 01/2019 - 10/2002
12	LH Receptors (LH Receptor)IBA 08/2019 - 01/2003
12	GonadotropinsIBA 01/2019 - 01/2003
11	Testosterone (Sustanon)FDA Link 01/2020 - 12/2003
10	Tumor Viral Antigens (Large T Antigen)IBA 01/2019 - 11/2002
10	AndrogensIBA 01/2019 - 11/2003
9	Estrogens (Estrogen)FDA Link 01/2016 - 05/2003
8	Proteins (Proteins, Gene)FDA Link 12/2016 - 10/2002
7	Inhibins (Inhibin)IBA 01/2019 - 05/2003
5	hecate-chorionic gonadotropin beta-subunit conjugateIBA 06/2009 - 05/2003
4	Hormones (Hormone)IBA 01/2022 - 12/2007
4	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2019 - 12/2003
4	Follicle Stimulating Hormone (Follitropin)FDA Link 01/2019 - 12/2003
4	Progesterone FDA LinkGeneric 01/2017 - 05/2005
4	ProlactinIBA 10/2013 - 04/2005
4	Estradiol (Delestrogen)FDA LinkGeneric 02/2013 - 08/2007
4	Aromatase (CYP19)IBA 03/2011 - 07/2003
4	inhibin-alpha subunitIBA 06/2008 - 05/2003
3	FSH Receptors (FSH Receptor)IBA 01/2019 - 03/2002
3	Estrogen ReceptorsIBA 01/2016 - 03/2006
3	Peptides (Polypeptides)IBA 03/2014 - 06/2008
3	Gonadal Steroid Hormones (Sex Hormones)IBA 11/2010 - 11/2003
3	Human beta Subunit Chorionic GonadotropinIBA 09/2010 - 04/2005
3	Messenger RNA (mRNA)IBA 06/2008 - 12/2003
2	SteroidsIBA 01/2022 - 02/2013
2	Zona Pellucida GlycoproteinsIBA 01/2022 - 03/2014
2	EnzymesIBA 01/2017 - 03/2006
2	GATA4 Transcription FactorIBA 01/2017 - 10/2004
2	Glycoproteins (Glycoprotein)IBA 12/2016 - 01/2012
2	Triglycerides (Triacylglycerol)IBA 12/2011 - 04/2008
2	Ubiquitin CIBA 03/2011 - 08/2007
1	CatecholaminesIBA 01/2022
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2022
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2020
1	Protein Sorting Signals (Signal Peptide)IBA 08/2019
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2019
1	cetrorelix (Cetrotide)FDA Link 01/2019
1	Cabergoline FDA LinkGeneric 10/2018
1	Dopamine Agonists (Dopamine Agonist)IBA 10/2018
1	AntigensIBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Steroid 11-beta-Hydroxylase (11 beta-Hydroxylase)IBA 01/2017
1	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 01/2017
1	Caspase 3 (Caspase-3)IBA 01/2017
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2017
1	C-Reactive ProteinIBA 04/2016
1	Phosphotransferases (Kinase)IBA 07/2015
1	Thymidine KinaseIBA 03/2014
1	Dihydrotestosterone (Androstanolone)IBA 02/2013
1	CholesterolIBA 02/2013
1	Fatty Acids (Saturated Fatty Acids)IBA 02/2013
1	Immunologic Factors (Immunomodulators)IBA 01/2013
1	AntibodiesIBA 01/2013
1	VaccinesIBA 01/2013
1	AutoantigensIBA 01/2012
1	HMGB3 ProteinIBA 01/2012

Therapy/Procedure

10	Therapeutics 01/2020 - 05/2005
7	Castration 01/2019 - 05/2003
4	Immunotherapy 01/2022 - 01/2012
4	Contraception (Birth Control) 09/2018 - 07/2002
2	Ovariectomy (Oophorectomy) 10/2018 - 10/2002
2	Drug Therapy (Chemotherapy) 09/2010 - 06/2008